The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy
Open accessAbstract
Unrestricted cell proliferation is a hallmark of cancer. Purines are basic components of nucleotides in cell proliferation, thus impaired purine metabolism is associated with the progression of cancer. The de novo biosynthesis of purine depends on six enzymes to catalyze the conversion of phosphoribosylpyrophosphate to inosine 5'-monophosphate. These enzymes cluster around mitochondria and microtubules to form purinosome, which is a multi-enzyme complex involved in de novo purine biosynthesis and purine nucleotides requirement. In this review, we highlighted the purine metabolism and purinosome biology with emphasis on the therapeutic potential of manipulating of purine metabolism or purinosome in cancers. We also reviewed current advances in our understanding of mammalian target of rapamycin (mTOR) for regulating purinosome formation or purine metabolism in cancers, and discussed the future prospects for targeting purinosome to treat cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
Understanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Cell cycle proteins as promising targets in cancer therapy
Otto, T., & Sicinski, P. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.138 · Cited by 1,858
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Serine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3557 · Cited by 1,673
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Regulation of uric acid metabolism and excretion
Maiuolo, J., Oppedisano, F., Gratteri, S., Muscoli, C., & Mollace, V. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.109 · Cited by 1,375
Cogliati, S., Frezza, C., Soriano, M. E., Varanita, T., Quintana-Cabrera, R., Corrado, M., Cipolat, S., Costa, V., Casarin, A., Gomes, L. C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.032 · Cited by 1,265
Glutamine and cancer: cell biology, physiology, and clinical opportunities
Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69600 · Cited by 1,262
Bar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1232044 · Cited by 1,080
Serine and glycine metabolism in cancer
Amelio, I., Cutruzzolá, F., Antonov, A., Agostini, M., & Melino, G. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.004 · Cited by 1,056
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
Maddocks, O. D. K., Berkers, C. R., Mason, S. M., Zheng, L., Blyth, K., Gottlieb, E., & Vousden, K. H. (2013) · Nature · doi:10.1038/nature11743 · Cited by 1,007
Serine and one-carbon metabolism in cancer
Yang, M., & Vousden, K. H. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.81 · Cited by 992
mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle
Ben-Sahra, I., Hoxhaj, G., Ricoult, S. J. H., Asara, J. M., & Manning, B. D. (2016) · Science · doi:10.1126/science.aad0489 · Cited by 795
Immunity, inflammation and cancer: a leading role for adenosine
Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3613 · Cited by 765
Cancer immunotherapy—immune checkpoint blockade and associated endocrinopathies.
Byun, D. J., Wolchok, J. D., Rosenberg, L. M., & Girotra, M. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.205 · Cited by 685
Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer
Parker, W. B. (2009) · Chemical Reviews · doi:10.1021/cr900028p · Cited by 622
Nilsson, R., Jain, M., Madhusudhan, N., Sheppard, N. G., Strittmatter, L., Kampf, C., Huang, J., Asplund, A., & Mootha, V. K. (2014) · Nature Communications · doi:10.1038/ncomms4128 · Cited by 607
Modulating the therapeutic response of tumours to dietary serine and glycine starvation
Maddocks, O. D. K., Athineos, D., Cheung, E. C., Lee, P., Zhang, T., van den Broek, N. J. F., Mackay, G. M., Labuschagne, C. F., Gay, D., Kruiswijk, F., et al. (2017) · Nature · doi:10.1038/nature22056 · Cited by 603
Reversible compartmentalization of de novo purine biosynthetic complexes in living cells
An, S., Kumar, R., Sheets, E. D., & Benkovic, S. J. (2008) · Science · doi:10.1126/science.1152241 · Cited by 585 · cited 3×
“The assembly and disassembly of purinosome can be regulated dynamically by cellular level of purine (10, 20), which directly activates the de novo purine biosynthesis (21, 22).”
BackgroundTissue of origin dictates branched-chain amino acid metabolism in mutant Kras -driven cancers
Mayers, J. R., Torrence, M. E., Danai, L. V., Papagiannakopoulos, T., Davidson, S. M., Bauer, M. R., Lau, A. N., Ji, B. W., Dixit, P. D., Hosios, A. M., et al. (2016) · Science · doi:10.1126/science.aaf5171 · Cited by 582
ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
van Geldermalsen, M., Wang, Q., Nagarajah, R., Marshall, A. D., Thoeng, A., Gao, D., Ritchie, W., Feng, Y., Bailey, C. G., Deng, N., et al. (2016) · Oncogene · doi:10.1038/onc.2015.381 · Cited by 580
A New View into the Regulation of Purine Metabolism: The Purinosome
Pedley, A. M., & Benkovic, S. J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.009 · Cited by 576
Extracellular purines, purinergic receptors and tumor growth
Di Virgilio, F., & Adinolfi, E. (2017) · Oncogene · doi:10.1038/onc.2016.206 · Cited by 559
One-carbon metabolism in cancer
Newman, A. C., & Maddocks, O. D. K. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.118 · Cited by 502
Yang, L., Achreja, A., Yeung, T.-L., Mangala, L. S., Jiang, D., Han, C., Baddour, J., Marini, J. C., Ni, J., Nakahara, R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.011 · Cited by 429
SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Hassanein, M., Hoeksema, M. D., Shiota, M., Qian, J., Harris, B. K., Chen, H., Clark, J. E., Alborn, W. E., Eisenberg, R., & Massion, P. P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2334 · Cited by 351
Gui, D. Y., Sullivan, L. B., Luengo, A., Hosios, A. M., Bush, L. N., Gitego, N., Davidson, S. M., Freinkman, E., Thomas, C. J., & Vander Heiden, M. G. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.006 · Cited by 323
Purinergic signalling and immune cells
Burnstock, G., & Boeynaems, J.-M. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9427-2 · Cited by 309
Purines, Purinergic Receptors, and Cancer
Di Virgilio, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1600 · Cited by 288
Characterization of a dynamic metabolon producing the defense compound dhurrin in sorghum
Laursen, T., Borch, J., Knudsen, C., Bavishi, K., Torta, F., Martens, H. J., Silvestro, D., Hatzakis, N. S., Wenk, M. R., Dafforn, T. R., et al. (2016) · Science · doi:10.1126/science.aag2347 · Cited by 281
Current treatment strategies for inhibiting mTOR in cancer
Chiarini, F., Evangelisti, C., McCubrey, J. A., & Martelli, A. M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.004 · Cited by 275
Tedeschi, P. M., Markert, E. K., Gounder, M., Lin, H., Dvorzhinski, D., Dolfi, S. C., Chan, L. L.-Y., Qiu, J., DiPaola, R. S., Hirshfield, K. M., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.393 · Cited by 260
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis
Shoshan, E., Mobley, A. K., Braeuer, R. R., Kamiya, T., Huang, L., Vasquez, M. E., Salameh, A., Lee, H. J., Kim, S. J., Ivan, C., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3110 · Cited by 242
Spatial colocalization and functional link of purinosomes with mitochondria
French, J. B., Jones, S. A., Deng, H., Pedley, A. M., Kim, D., Chan, C. Y., Hu, H., Pugh, R. J., Zhao, H., Zhang, Y., et al. (2016) · Science · doi:10.1126/science.aac6054 · Cited by 237
NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
Karki, R., Man, S. M., Malireddi, R. K. S., Kesavardhana, S., Zhu, Q., Burton, A. R., Sharma, B. R., Qi, X., Pelletier, S., Vogel, P., et al. (2016) · Nature · doi:10.1038/nature20597 · Cited by 213
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Vernieri, C., Casola, S., Foiani, M., Pietrantonio, F., de Braud, F., & Longo, V. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0615 · Cited by 202
Alvarado, A. G., Thiagarajan, P. S., Mulkearns-Hubert, E. E., Silver, D. J., Hale, J. S., Alban, T. J., Turaga, S. M., Jarrar, A., Reizes, O., Longworth, M. S., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.12.001 · Cited by 187
Linking metabolic reprogramming to therapy resistance in cancer
Morandi, A., & Indraccolo, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.12.004 · Cited by 177
Cancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling
Corbet, C., & Feron, O. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.01.002 · Cited by 172
Membrane cholesterol access into a G-protein-coupled receptor
Guixà-González, R., Albasanz, J. L., Rodriguez-Espigares, I., Pastor, M., Sanz, F., Martí-Solano, M., Manna, M., Martinez-Seara, H., Hildebrand, P. W., Martín, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms14505 · Cited by 172
Amino-acid transporters in T-cell activation and differentiation
Ren, W., Liu, G., Yin, J., Tan, B., Wu, G., Bazer, F. W., Peng, Y., & Yin, Y. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.222 · Cited by 166
Self-citationGlycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response
Gill, K. S., Fernandes, P., O’Donovan, T. R., McKenna, S. L., Doddakula, K., Power, D. G., Soden, D. M., & Forde, P. F. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.06.005 · Cited by 161
A systems study reveals concurrent activation of AMPK and mTOR by amino acids
Dalle Pezze, P., Ruf, S., Sonntag, A. G., Langelaar-Makkinje, M., Hall, P., Heberle, A. M., Razquin Navas, P., van Eunen, K., Tölle, R. C., Schwarz, J. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13254 · Cited by 148
Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase
Emmanuel, N., Ragunathan, S., Shan, Q., Wang, F., Giannakou, A., Huser, N. H., Jin, G., Myers, J. S., Abraham, R. T., & Ünsal-Kaçmaz, K. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.043 · Cited by 146
Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?
Kumar, V. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9349-9 · Cited by 144
Wong, C. C., Qian, Y., Li, X., Xu, J., Kang, W., TONG, J. H. M., To, K., Ye, J., Li, W., Chen, H., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.011 · Cited by 138
Erratum: Amino-acid transporters in T-cell activation and differentiation
Ren, W., Liu, G., Yin, J., Tan, B., Wu, G., Bazer, F. W., Peng, Y., & Yin, Y. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.207 · Cited by 138
Self-citationGoswami, M. T., Chen, G., Chakravarthi, B. V. S. K., Pathi, S. S., Anand, S. K., Carskadon, S. L., Giordano, T. J., Chinnaiyan, A. M., Thomas, D. G., Palanisamy, N., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4352 · Cited by 132
Zhao, H., Chiaro, C. R., Zhang, L., Smith, P. B. W., Chan, C. Y., Pedley, A. M., Pugh, R. J., French, J. B., Patterson, A. D., & Benkovic, S. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628701 · Cited by 127
Adenosine-to-inosine RNA editing meets cancer
Dominissini, D., Moshitch-Moshkovitz, S., Amariglio, N., & Rechavi, G. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr124 · Cited by 115
Karigane, D., Kobayashi, H., Morikawa, T., Ootomo, Y., Sakai, M., Nagamatsu, G., Kubota, Y., Goda, N., Matsumoto, M., Nishimura, E. K., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.05.013 · Cited by 112
Purinosome formation as a function of the cell cycle
Chan, C. Y., Zhao, H., Pugh, R. J., Pedley, A. M., French, J. B., Jones, S. A., Zhuang, X., Jinnah, H. A., Huang, T. J., & Benkovic, S. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423009112 · Cited by 108
mTORC1 signaling and IL‐17 expression: Defining pathways and possible therapeutic targets
Ren, W., Yin, J., Duan, J., Liu, G., Tan, B., Yang, G., Wu, G., Bazer, F. W., Peng, Y., & Yin, Y. (2015) · European Journal of Immunology · doi:10.1002/eji.201545886 · Cited by 105
Self-citationRen, W., Yin, J., Xiao, H., Chen, S., Liu, G., Tan, B., Li, N., Peng, Y., Li, T., Zeng, B., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00685 · Cited by 103
Self-citationGPCRs regulate the assembly of a multienzyme complex for purine biosynthesis
Verrier, F., An, S., Ferrie, A. M., Sun, H., Kyoung, M., Deng, H., Ye, F., & Benkovic, S. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.690 · Cited by 89
Hsp70/Hsp90 chaperone machinery is involved in the assembly of the purinosome
French, J. B., Zhao, H., An, S., Niessen, S., Deng, Y., Cravatt, B. F., & Benkovic, S. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300173110 · Cited by 89
Yin, J., Li, Y., Zhu, X., Han, H. L., Ren, W., Chen, S., Bin, P., Liu, G., Huang, X., Fang, R., et al. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b02746 · Cited by 83
Self-citationImmunoregulatory activity of adenosine and its role in human cancer progression
Muller-Haegele, S., Müller, L., & Whiteside, T. L. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.915739 · Cited by 82
Novel Developments in the Use of Antimetabolites
Peters, G. J. (2014) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2014.894197 · Cited by 81
Ristić, B., Bhutia, Y. D., & Ganapathy, V. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.003 · Cited by 78
Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer
Barfeld, S., Fazli, L., Persson, M., Marjavaara, L., Urbanucci, A., Kaukoniemi, K. M., Rennie, P., Ceder, Y., Chabes, A., Visakorpi, T., et al. (2015) · OncoTarget · doi:10.18632/oncotarget.3494 · Cited by 76
Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH
Allen, E. L., Ulanet, D., Pirman, D. A., Mahoney, C. E., Coco, J., Si, Y., Chen, Y., Huang, L., Ren, J., Choe, S. E., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.052 · Cited by 74
Barešová, V., Škopová, V., Sikora, J., Patterson, D. W., Sovová, J., Zikánová, M., & Kmoch, S. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr591 · Cited by 72
FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10
Xie, T., Geng, J., Wang, Y., Wang, L., Huang, M., Chen, J., Zhang, K., Xue, L., Liu, X., Mao, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14351 · Cited by 70
Mapping protein-protein proximity in the purinosome
Deng, Y., Gam, J., French, J. B., Zhao, H., An, S., & Benkovic, S. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407056 · Cited by 69
Protein restriction and cancer
Yin, J., Ren, W., Huang, X., Li, T., & Yin, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.03.004 · Cited by 69
Self-citationCell cycle regulation of purine synthesis by phosphoribosyl pyrophosphate and inorganic phosphate
Fridman, A., Saha, A., Chan, A., Casteel, D. E., Pilz, R. B., & Boss, G. R. (2013) · Biochemical Journal · doi:10.1042/bj20130153 · Cited by 66
Tiloke, C., Phulukdaree, A., & Chuturgoon, A. A. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2015.0113 · Cited by 59
Dynamic Architecture of the Purinosome Involved in Human De Novo Purine Biosynthesis
Kyoung, M., Russell, S. J., Kohnhorst, C. L., Esemoto, N. N., & An, S. (2014) · Biochemistry · doi:10.1021/bi501480d · Cited by 54
Mthfs is an Essential Gene in Mice and a Component of the Purinosome
Field, M. S., Anderson, D. D., & Stover, P. J. (2011) · Frontiers in Genetics · doi:10.3389/fgene.2011.00036 · Cited by 53
Glycosome turnover inLeishmania majoris mediated by autophagy
Cull, B., Godinho, J. L. P., Rodrigues, J. C. F., Frank, B., Schurigt, U., Williams, R., Coombs, G. H., & Mottram, J. C. (2014) · Autophagy · doi:10.4161/auto.36438 · Cited by 51
Effects of Lysine deficiency and Lys-Lys dipeptide on cellular apoptosis and amino acids metabolism
Yin, J., Li, Y., Han, H. L., Zheng, J., Wang, L., Ren, W., Chen, S., Wu, F., Fang, R., Huang, X., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600754 · Cited by 48
Self-citationRocha, K. C., Vieira, M. L., Beltrame, R. L., Cartum, J., Alves, S. I. P. M. D. N., Azzalis, L. A., Junqueira, V. B. C., Pereira, E. C., & Fonseca, F. L. A. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2015.0145 · Cited by 45
A New Cell-Cycle Target in Cancer — Inhibiting Cyclin D–Dependent Kinases 4 and 6
Sherr, C. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1612343 · Cited by 44
Rosenthal, E. L., Chung, T. K., Parker, W. B., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv196 · Cited by 41
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.001 · Cited by 40
Barešová, V., Krijt, M., Škopová, V., Součková, O., Kmoch, S., & Zikánová, M. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.08.004 · Cited by 37
Soares, A., Costa, V. M., Diniz, C., & Fresco, P. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12280 · Cited by 35
Sakuma, S., Abe, M., Kohda, T., & Fujimoto, Y. (2014) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.14-34 · Cited by 33
Schilling, D., Garrido, C., Combs, S. E., & Multhoff, G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.015 · Cited by 33
Ogura, J., Kuwayama, K., Sasaki, S., Kaneko, C., Koizumi, T., Yabe, K., Tsujimoto, T., Takeno, R., Takaya, A., Kobayashi, M., et al. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.021 · Cited by 31
Methotrexate induced differentiation in colon cancer cells is primarily due to purine deprivation
Singh, R., Fouladi-Nashta, A. A., Li, D., Halliday, N., Barrett, D. A., & Sinclair, K. D. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20908 · Cited by 29
Role of HSP90 in the Regulation of de Novo Purine Biosynthesis
Pedley, A. M., Karras, G. I., Zhang, X., Lindquist, S. L., & Benkovic, S. J. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00140 · Cited by 29
Gene set analysis of purine and pyrimidine antimetabolites cancer therapies
Fridley, B. L., Batzler, A. J., Li, L., Li, F., Matimba, A., Jenkins, G. D., Ji, Y., Wang, L., & Weinshilboum, R. M. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834a48a9 · Cited by 27
Dhillon, H., Mamidi, S., McClean, P. E., & Reindl, K. M. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2015.0152 · Cited by 24
G-protein-coupled receptor regulation ofde novopurine biosynthesis: a novel druggable mechanism
Ye, F., French, J. B., Zhao, H., & Benkovic, S. J. (2013) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2013.801237 · Cited by 21
Approaches and techniques to characterize cancer metabolism in vitro and in vivo
Zaimenko, I., Lisec, J., Stein, U., & Brenner, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.08.004 · Cited by 19
The GLU that Holds Cancer Together: Targeting GLUtamine Transporters in Breast Cancer
Moses, M. A., & Neckers, L. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.010 · Cited by 17
Detecting Purinosome Metabolon Formation with Fluorescence Microscopy
Pedley, A. M., & Benkovic, S. J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7759-8_17 · Cited by 13
Li, C., Jeong, Y., & Kim, M. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3865 · Cited by 8
Law, V., Dong, S., Rosales, J. L., Jeong, M.-Y., Zochodne, D. W., & Lee, K. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00238 · Cited by 5
Faster light adaptation improves productivity
Hines, P. J. (2016) · Science · doi:10.1126/science.354.6314.843-b · Cited by 5
Stressed-Out HSCs Turn Up p38α and Purine to Proliferate
Essers, M. A. G. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.07.013 · Cited by 3
Kim, J. H., Lee, K. J., Kwon, J. H., Lee, H. J., Park, S. J., Cheon, J. H., Kim, W. H., & Kim, T. I. (2016) · Gastroenterology · doi:10.1016/s0016-5085(16)33441-2 · Cited by 2
Cited by
From purines to purinergic signalling: molecular functions and human diseases
Huang, Z., Xie, N., Illes, P., Di Virgilio, F., Ulrich, H., Semyanov, A., Verkhratsky, A., Sperlagh, B., Yu, S.-G., Huang, C., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00553-z · Cited by 489
Exploring the Prognosis-Related Genetic Variation in Gastric Cancer Based on mGWAS
Zhang, Y., Lyu, Y., Chen, L., Cao, K., Chen, J., He, C., Lyu, X., Jiang, Y., Xiang, J., Liu, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015259 · Cited by 5
Metadata
- Authors
- Yin, J., Ren, W., Huang, X., Deng, J., Li, T., & Yin, Y.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-07-30
- Volume
- 9
- Pages
- 1697-1697
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2885303230
- Cited by
- 450
- References
- 98
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.